Rus Eng
Main / Portfolio / Endocrinology / RinFast (Insulin Aspart)
  • The most common insulin analogues of ultra-short-term effect
  • Substitution of proline with aspartic acid
  • Higher speed of absorption in comparison with usual human insulin
  • The effect starts in 10–20 min after subcutaneous injection
  • Maximal effect in 1–3 hours
  • The effect lasts for 3–5 hours

Development of analogues portfolio RinFast (Insulin Aspart)

GEROPHARM is developing a full line of insulin bio analogues that are at different stages of studying.

Advantages of bio analogues:

  • less variable, more stable effect;
  • economic efficiency.
Name of
the drug
Stage:
Pharmaceut. Development
Preclinical Trials
Clinical Trials
1
2
3
registration
RinFast (Insulin Aspart)

You are a health care professional?

Go up